| scholarly article | Q13442814 |
| P50 | author | C Norman Coleman | Q104281354 |
| P2093 | author name string | Scott R Magnuson | |
| Molykutty John-Aryankalayil | |||
| Michael T Falduto | |||
| Sanjeewani T Palayoor | |||
| Adeola Y Makinde | |||
| P2860 | cites work | External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing | Q40543778 |
| p21/CDKN1A mediates negative regulation of transcription by p53. | Q40647697 | ||
| MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway. | Q54300156 | ||
| Biologic basis for altered fractionation schemes. | Q54519529 | ||
| MiR-21 is up-regulated in psoriasis and suppresses T cell apoptosis | Q57947473 | ||
| Characterization of Molecular and Functional Alterations of Tumor Endothelial Cells to Design Anti-Angiogenic Strategies | Q58831511 | ||
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| miR-15 and miR-16 induce apoptosis by targeting BCL2 | Q24536069 | ||
| Multiple roles of ATM in monitoring and maintaining DNA integrity | Q24594847 | ||
| Combining radiotherapy and cancer immunotherapy: a paradigm shift | Q27021428 | ||
| Radiation survivors: understanding and exploiting the phenotype following fractionated radiation therapy | Q27026696 | ||
| Transforming growth factor beta in tissue fibrosis | Q28239292 | ||
| Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia | Q28306913 | ||
| MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts | Q28511032 | ||
| Transcriptional control of human p53-regulated genes | Q29617650 | ||
| Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs | Q29618428 | ||
| Transcriptional activation of miR-34a contributes to p53-mediated apoptosis | Q29619556 | ||
| Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis | Q29619873 | ||
| The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors | Q30435946 | ||
| Revelation of p53-independent function of MTA1 in DNA damage response via modulation of the p21 WAF1-proliferating cell nuclear antigen pathway | Q33744407 | ||
| Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cells | Q34145858 | ||
| microRNA regulation of inflammatory responses | Q34245279 | ||
| Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology | Q34560071 | ||
| The p53-Mdm2 module and the ubiquitin system. | Q35036580 | ||
| Linking radiation oncology and imaging through molecular biology (or now that therapy and diagnosis have separated, it's time to get together again!). | Q35165507 | ||
| Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy | Q35540109 | ||
| Maximizing tumor immunity with fractionated radiation | Q35916615 | ||
| Gene expression profile of coronary artery cells treated with nonsteroidal anti-inflammatory drugs reveals off-target effects | Q36017548 | ||
| miR-140-3p regulation of TNF-α-induced CD38 expression in human airway smooth muscle cells | Q36309177 | ||
| Radiation as an immunological adjuvant: current evidence on dose and fractionation. | Q36347177 | ||
| Differential usage of non-homologous end-joining and homologous recombination in double strand break repair | Q36522562 | ||
| Hypofractionation in radiotherapy | Q36725812 | ||
| Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma. | Q36889632 | ||
| Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. | Q36983211 | ||
| BRCA1 and BRCA2: different roles in a common pathway of genome protection | Q37149848 | ||
| mRNA Expression Profiles for Prostate Cancer following Fractionated Irradiation Are Influenced by p53 Status | Q37246446 | ||
| Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody | Q37351567 | ||
| Targeting the DNA damage response for cancer therapy | Q37509949 | ||
| The dynamic roles of TGF-β in cancer | Q37801347 | ||
| Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients | Q37815504 | ||
| MicroRNAs: new players in the DNA damage response | Q37823782 | ||
| Organ-sparing radiation therapy for head and neck cancer | Q37905536 | ||
| Radiation fibrosis--current clinical and therapeutic perspectives | Q38011370 | ||
| Radiation therapy and immunotherapy: implications for a combined cancer treatment. | Q38049407 | ||
| Fractionated Radiation Therapy Can Induce a Molecular Profile for Therapeutic Targeting | Q38505337 | ||
| MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2. | Q39613855 | ||
| Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity | Q40010222 | ||
| Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. | Q40144504 | ||
| P433 | issue | 7 | |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 1002-1015 | |
| P577 | publication date | 2014-04-30 | |
| P1433 | published in | Molecular Cancer Research | Q2751014 |
| P1476 | title | Differential expression of stress and immune response pathway transcripts and miRNAs in normal human endothelial cells subjected to fractionated or single-dose radiation | |
| P478 | volume | 12 |
| Q42587971 | Comprehensive molecular tumor profiling in radiation oncology: How it could be used for precision medicine |
| Q38724657 | Emergence of miR-34a in radiation therapy |
| Q90182038 | Emerging Challenges of Radiation-Associated Cardiovascular Dysfunction (RACVD) in Modern Radiation Oncology: Clinical Practice, Bench Investigation, and Multidisciplinary Care |
| Q26747120 | Evaluating biomarkers to model cancer risk post cosmic ray exposure |
| Q38952268 | Exploiting Gene Expression Kinetics in Conventional Radiotherapy, Hyperfractionation, and Hypofractionation for Targeted Therapy. |
| Q33751085 | Gene and miRNA expression profiles of mouse Lewis lung carcinoma LLC1 cells following single or fractionated dose irradiation. |
| Q38654155 | Immunomodulatory effects of radiation: what is next for cancer therapy? |
| Q64943265 | Key mechanisms involved in ionizing radiation-induced systemic effects. A current review. |
| Q90451098 | Long-term Tumor Adaptation after Radiotherapy: Therapeutic Implications for Targeting Integrins in Prostate Cancer |
| Q27025405 | MicroRNA in radiotherapy: miRage or miRador? |
| Q60548676 | Microarray analysis of miRNA expression profiles following whole body irradiation in a mouse model |
| Q92995794 | Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1 |
| Q45058787 | Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate. Report of an NCI Workshop, September 19, 2016. |
| Q30151428 | The Radiation Stress Response: Of the People, By the People and For the People |
| Q41778571 | Tumor Induction in Mice After Localized Single- or Fractionated-Dose Irradiation: Differences in Tumor Histotype and Genetic Susceptibility Based on Dose Scheduling |
| Q52568697 | Workshop Report for Cancer Research: Defining the Shades of Gy: Utilizing the Biological Consequences of Radiotherapy in the Development of New Treatment Approaches-Meeting Viewpoint. |
Search more.